FIELD: medicine, dermatology. SUBSTANCE: invention proposes to use melaxen as a synthetic analog of pineal gland hormone in the dose 0.5-1.5 mg before night sleep by oral route for 7-20 days. Method can be used for treatment of patients with eczema and psoriasis. EFFECT: simplified treatment schedule, decreased relapse period treatment, prolonged remission periods. 2 tbl, 1 dwg, 2 ex _
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PSORIASIS | 0 |
|
SU1821217A1 |
METHOD OF TREATING PSORIASIS | 2012 |
|
RU2500443C1 |
METHOD OF TREATMENT AND PROPHYLAXIS OF CHRONICAL DERMATOSES | 1997 |
|
RU2142266C1 |
METHOD OF TREATING VIDAL'S DISEASE | 2008 |
|
RU2396963C1 |
METHOD FOR TREATING GUTTATE PSORIASIS | 2018 |
|
RU2697415C1 |
METHOD FOR TREATMENT OF ALLERGIC DERMATOSIS | 2001 |
|
RU2230549C2 |
METHOD OF TREATING CHRONIC INFLAMMATORY DERMATOSES IN CHILDREN | 1998 |
|
RU2175244C2 |
METHOD FOR TREATING ATYPICAL FORM OF PSORIASIS | 2000 |
|
RU2200594C2 |
METHOD OF TREATMENT OF NEURODERMITE AND PSORIASIS | 1992 |
|
RU2007179C1 |
LIPID COMPLEX FOR TREATMENT OF CHRONIC DERMATOSES | 1998 |
|
RU2159118C2 |
Authors
Dates
2002-03-10—Published
1999-12-06—Filed